150 related articles for article (PubMed ID: 35682739)
1. Enalapril Diminishes the Diabetes-Induced Changes in Intestinal Morphology, Intestinal RAS and Blood SCFA Concentration in Rats.
Jaworska K; Kopacz W; Koper M; Szudzik M; Gawryś-Kopczyńska M; Konop M; Hutsch T; Chabowski D; Ufnal M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682739
[TBL] [Abstract][Full Text] [Related]
2. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
4. Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.
Wehbi GJ; Zimpelmann J; Carey RM; Levine DZ; Burns KD
Am J Physiol Renal Physiol; 2001 Feb; 280(2):F254-65. PubMed ID: 11208601
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
6. Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker.
Konop M; Radkowski M; Grochowska M; Perlejewski K; Samborowska E; Ufnal M
Biomarkers; 2018; 23(4):380-385. PubMed ID: 29363331
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.
Hartmann JF; Szemplinski M; Hayes NS; Keegan ME; Slater EE
J Hypertens; 1988 Aug; 6(8):677-83. PubMed ID: 2846685
[TBL] [Abstract][Full Text] [Related]
9. [Effect of enalapril on diabetic rat myocardial ultrastructure].
Xu CS; Li ZL; Xue SR; Yan QN; Wu HC
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1726-7. PubMed ID: 18024300
[TBL] [Abstract][Full Text] [Related]
10. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
Kosugi T; Heinig M; Nakayama T; Matsuo S; Nakagawa T
Am J Pathol; 2010 Feb; 176(2):619-29. PubMed ID: 20042665
[TBL] [Abstract][Full Text] [Related]
11. Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands.
Cano IP; Dionisio TJ; Cestari TM; Calvo AM; Colombini-Ishikiriama BL; Faria FAC; Siqueira WL; Santos CF
PLoS One; 2019; 14(5):e0217030. PubMed ID: 31116771
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system modulation through enalapril and/or exercise training improves visceral adiposity in obese mice.
Alexandre-Santos B; Magliano DC; Giori IG; Medeiros GRO; Vieira CP; Conte-Junior CA; Nobrega ACLD; Frantz EDC
Life Sci; 2022 Feb; 291():120269. PubMed ID: 34974075
[TBL] [Abstract][Full Text] [Related]
13. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
15. Enalapril treatment restores the decreased proximal tubule reabsorption in response to acute volume expansion in diabetic rats.
Yu T; Khraibi AA
Life Sci; 2008 Aug; 83(9-10):364-8. PubMed ID: 18671986
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
Machackova J; Liu X; Lukas A; Dhalla NS
Mol Cell Biochem; 2004 Jun; 261(1-2):271-8. PubMed ID: 15362513
[TBL] [Abstract][Full Text] [Related]
17. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats.
Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y
J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
Kalinyak JE; Sechi LA; Griffin CA; Don BR; Tavangar K; Kraemer FB; Hoffman AR; Schambelan M
J Am Soc Nephrol; 1993 Dec; 4(6):1337-45. PubMed ID: 8130360
[TBL] [Abstract][Full Text] [Related]
19. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
[TBL] [Abstract][Full Text] [Related]
20. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
